Ascendis Pharma A/s Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Ascendis Pharma A/S reports a Form 4 filing detailing the acquisition of ordinary shares by EVP & Chief Financial Officer, Scott Thomas Smith.
NASDAQ
Jean Jacques Bienaime, a Director at Ascendis Pharma A/S, reported transactions involving the acquisition of ordinary shares on May 29, 2026.
NASDAQ
Ascendis Pharma A/S reports an acquisition of ordinary shares by its EVP & Chief Financial Officer, Scott Thomas Smith.
NASDAQ
Flemming Steen Jensen, EVP & Product Supply and Quality at Ascendis Pharma A/S, reported a sale of 19,460 ordinary shares.